Proteins without unique 3D structures: Biotechnological applications of intrinsically unstable/disordered proteins

Biotechnology Journal

Volumn 10, Issue 3, 2015, Pages 356-366

  Uversky, Vladimir N ^a,b,c,d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c INSTITUTE OF CYTOLOGY   (Russian Federation)

^d INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

Amino acid sequence; IDP; Intrinsic disorder; Protein conformation; Protein folding

Indexed keywords

AMINO ACIDS; BIOTECHNOLOGY; DRUG DELIVERY; MOBILE SECURITY; NANOPARTICLES; PEPTIDES; PROTEIN FOLDING; PURIFICATION; RECOMBINANT PROTEINS; SOLUBILITY;

AMINO ACID SEQUENCE; BIOTECHNOLOGICAL APPLICATIONS; CONFORMATIONAL BEHAVIOR; IDP; INTRINSIC DISORDER; INTRINSICALLY DISORDERED PROTEINS; PROTEIN CONFORMATION; PROTEIN ISOLATION AND PURIFICATION;

PROTEINS;

ACID; BIOPOLYMER; CALMODULIN BINDING PROTEIN; CARRIER PROTEIN; CELL EXTRACT; CELL PENETRATING PEPTIDE; DOXORUBICIN; DRUG CARRIER; ELASTIN; GLOBULAR PROTEIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; INTRINSICALLY DISORDERED PROTEIN; MALTOSE BINDING PROTEIN; NANOPARTICLE; POLYPEPTIDE; PROTEOME; RECOMBINANT PROTEIN; THIOREDOXIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BIOTECHNOLOGICAL PROCEDURES; CARBOXY TERMINAL SEQUENCE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; HEAT TREATMENT; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR WEIGHT; NONHUMAN; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN STRUCTURE; SOLUBILIZATION; ANIMAL; BIOTECHNOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; PROCEDURES;

ANIMALS; BIOTECHNOLOGY; DRUG DELIVERY SYSTEMS; HUMANS; INTRINSICALLY DISORDERED PROTEINS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 84924524058     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201400374     Document Type: Article

References (143)

1. Anson, M. L., Mirsky, A. E., The effect of denaturation on the viscosity of protein systems. J. Gen. Physiol. 1932, 15, 341350.
2. Mirsky, A. E., Pauling, L., On the structure of native, denatured and coagulated proteins. Proc. Natl. Acad. Sci. USA 1936, 22, 439-447.
3. Neurath, H., Greenstein, J. P., Putnam, F. W., Erickson, J. O., The chemistry of protein denaturation. Chem. Rev. 1944, 34, 157-265.
4. Tanford, C., Protein denaturation. Adv. Protein Chem. 1968, 23, 121-282.
5. Ptitsyn, O., Molten globule and protein folding. Adv. Protein Chem. 1995, 47, 83-229.
6. Uversky, V. N., Ptitsyn, O. B., "Partly folded" state, a new equilibrium state of protein molecules: Four-state guanidinium chloride-induced unfolding of beta-lactamase at low temperature. Biochemistry 1994, 33, 2782-2791.
7. Ptitsyn, O. B., Structures of folding intermediates. Curr. Opin. Struct. Biol. 1995, 5, 74-78.
8. Ptitsyn, O. B., Molten globule and protein folding. Adv. Protein Chem. 1995, 47, 83-229.
9. Uversky, V. N., Ptitsyn, O. B., Further evidence on the equilibrium "pre-molten globule state": Four-state guanidinium chloride-induced unfolding of carbonic anhydrase B at low temperature. J. Mol. Biol. 1996, 255, 215-228.
10. Uversky, V. N., Karnoup, A. S., Segel, D. J., Seshadri, S. et al., Anion-induced folding of Staphylococcal nuclease: Characterization of multiple equilibrium partially folded intermediates. J. Mol. Biol. 1998, 278, 879-894.
11. Uversky, V. N., Fink, A. L., Do protein molecules have a native-like topology in the pre-molten globule state? Biochemistry (Mosc.) 1999, 64, 552-555.
12. Tcherkasskaya, O., Uversky, V. N., Denatured collapsed states in protein folding: Example of apomyoglobin. Proteins 2001, 44, 244-254.
13. Uversky, V. N., Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: Which way to go? Cell. Mol. Life Sci. 2003, 60, 1852-1871.
14. Uversky, V. N., Natively unfolded proteins: A point where biology waits for physics. Protein Sci. 2002, 11, 739-756.
15. Bracken, C., Iakoucheva, L. M., Romero, P. R., Dunker, A. K., Combining prediction, computation and experiment for the characterization of protein disorder. Curr. Opin. Struct. Biol. 2004, 14, 570-576.
16. Daughdrill, G. W., Pielak, G. J., Uversky, V. N., Cortese, M. S., Dunker, A. K., Natively disordered proteins. in: Buchner, J., Kiefhaber, T. (Eds.), Handbook of Protein Folding, Wiley-VCH, Verlag GmbH & Co., Weinheim, Germany 2005, pp. 271-353.
17. Receveur-Brechot, V., Bourhis, J. M., Uversky, V. N., Canard, B., Longhi, S., Assessing protein disorder and induced folding. Proteins 2006, 62, 24-45.
18. Dunker, A. K., Obradovic, Z., Romero, P., Garner, E. C., Brown, C. J., Intrinsic protein disorder in complete genomes. Genome Inform. Ser. Workshop Genome Inform. 2000, 11, 161-171.
19. Uversky, V. N., The mysterious unfoldome: Structureless, underappreciated, yet vital part of any given proteome., WJ. Biomed. Biotechnol. 2010, 2010, 568068.
20. Ward, J. J., Sodhi, J. S., McGuffin, L. J., Buxton, B. F., Jones, D. T., Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J. Mol. Biol. 2004, 337, 635-645.
21. Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M. et al., Intrinsically disordered protein. J. Mol. Graph. Model. 2001, 19, 26-59.
22. Uversky, V. N., Dunker, A. K., Understanding protein non-folding. Biochim. Biophys. Acta 2010, 1804, 1231-1264.
23. Iakoucheva, L. M., Brown, C. J., Lawson, J. D., Obradovic, Z., Dunker, A. K., Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 2002, 323, 573-584.
24. Dunker, A. K., Cortese, M. S., Romero, P., Iakoucheva, L. M., Uversky, V. N., Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J. 2005, 272, 5129-5148.
25. Uversky, V. N., Oldfield, C. J., Dunker, A. K., Showing your ID: Intrinsic disorder as an ID for recognition, regulation and cell signaling. J. Mol. Recognit. 2005, 18, 343-384.
26. Wright, P. E., Dyson, H. J., Intrinsically unstructured proteins: Re-assessing the protein structure-function paradigm. J. Mol. Biol. 1999, 293, 321-331.
27. Uversky, V. N., Gillespie, J. R., Fink, A. L, Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 2000, 41, 415-427.
28. Dyson, H. J., Wright, P. E., Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 2002, 12, 54-60.
29. Tompa, P., Intrinsically unstructured proteins. Trends Biochem. Sci. 2002, 27, 527-533.
30. Uversky, V. N., Natively unfolded proteins: A point where biology waits for physics. Protein Sci. 2002, 11, 739-756.
31. Dunker, A. K., Oldfield, C. J., Meng, J., Romero, P. et al., The unfoldomics decade: An update on intrinsically disordered proteins. BMC Genomics 2008, 9, S1.
32. Dyson, H. J., Wright, P. E., Intrinsically unstructured proteins and their functions. Rev. Mol. Cell. Biol. 2005, 6, 197-208.
33. Lee, B. M., Xu, J., Clarkson, B. K., Martinez-Yamout, M. A. et al., Induced fit and "lock and key" recognition of 5S RNA by zinc fingers of transcription factor IIIA. J. Mol. Biol. 2006, 357, 275-291.
34. Sugase, K., Dyson, H. J., Wright, P. E., Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature 2007, 447, 1021-1025.
35. Cortese, M. S., Uversky, V. N., Dunker, A. K., Intrinsic disorder in scaffold proteins: Getting more from less. Prog. Biophys. Mol. Biol. 2008, 98, 85-106.
36. Dunker, A. K., Silman, I., Uversky, V. N., Sussman, J. L., Function and structure of inherently disordered proteins. Curr. Opin. Struct. Biol. 2008, 18, 756-764.
37. Dunker, A. K., Obradovic, Z., The protein trinity - linking function and disorder. Nat. Biotechnol. 2001, 19, 805-806.
38. Dunker, A. K., Brown, C. J., Lawson, J. D., Iakoucheva, L. M., Obradovic, Z., Intrinsic disorder and protein function. Biochemistry 2002, 41, 6573-6582.
39. Dunker, A. K., Brown, C. J., Obradovic, Z., Identification and functions of usefully disordered proteins. Adv. Protein Chem. 2002, 62, 25-49.
40. Uversky, V. N., What does it mean to be natively unfolded? Eur. J. Biochem. 2002, 269, 2-12.
41. Radivojac, P., Iakoucheva, L. M., Oldfield, C. J., Obradovic, Z. et al., Intrinsic disorder and functional proteomics. Biophys. J. 2007, 92, 1439-1456.
42. Uversky, V. N., Oldfield, C. J., Dunker, A. K., Intrinsically disordered proteins in human diseases: Introducing the D2 concept. Annu. Rev. Biophys. 2008, 37, 215-246.
43. Uversky, V. N., A protein-chameleon: Conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J. Biomol. Struct. Dyn. 2003, 21, 211-234.
44. Uversky, V. N., Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J. Neurochem. 2007, 103, 17-37.
45. Uversky, V. N., Alpha-synuclein misfolding and neurodegenerative diseases. Curr. Protein Pept. Sci. 2008, 9, 507-540.
46. Uversky, V. N., Eliezer, D., Biophysics of Parkinson's disease: Structure and aggregation of alpha-synuclein. Curr. Protein Pept. Sci. 2009, 10, 483-499.
47. Breydo, L., Wu, J. W., Uversky, V. N., Alpha-synuclein misfolding and Parkinson's disease. Biochim. Biophys. Acta 2012, 1822, 261-285.
48. Alderson, T. R., Markley, J. L., Biophysical characterization of alpha-synuclein and its controversial structure. Intrinsically Disord. Proteins 2013, 1, 18-39.
49. von Bergen, M., Barghorn, S., Jeganathan, S., Mandelkow, E. M., Mandelkow, E., Spectroscopic approaches to the conformation of tau protein in solution and in paired helical filaments. Neurodegener. Dis. 2006, 3, 197-206.
50. Kirkitadze, M. D., Condron, M. M., Teplow, D. B., Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J. Mol. Biol. 2001, 312, 1103-1119.
51. Wells, M., Tidow, H., Rutherford, T. J., Markwick, P. et al., Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. Proc. Natl. Acad. Sci. USA 2008, 105, 5762-5767.
52. Oldfield, C. J., Meng, J., Yang, J. Y., Yang, M. Q. et al., Flexible nets: Disorder and induced fit in the associations of p53 and 14-3-3 with their partners. BMC Genomics 2008, 9, S1.
53. Uversky, V. N., Dunker, A. K., Understanding protein non-folding. Biochim. Biophys. Acta 2010, 1804, 1231-1264.
54. James, T. L., Liu, H., Ulyanov, N. B., Farr-Jones, S. et al., Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 1997, 94, 10086-10091.
55. Zahn, R., Liu, A., Luhrs, T., Riek, R. et al., NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. USA 2000, 97, 145-150.
56. Mark, W. Y., Liao, J. C., Lu, Y., Ayed, A. et al., Characterization of segments from the central region of BRCA1: An intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? J. Mol. Biol. 2005, 345, 275-287.
57. Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M. et al., Intrinsically disordered protein. J. Mol. Graph. Model. 2001, 19, 26-59.
58. Romero, P., Obradovic, Z., Li, X., Garner, E. C. et al., Sequence complexity of disordered protein. Proteins 2001, 42, 38-48.
59. Uversky, V. N., Intrinsically disordered proteins and their environment: Effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding. Protein J. 2009, 28, 305-325.
60. Uversky, V. N., Li, J., Fink, A. L., Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 2001, 276, 10737-10744.
61. Permyakov, S. E., Millett, I. S., Doniach, S., Permyakov, E. A., Uversky, V. N., Natively unfolded C-terminal domain of caldesmon remains substantially unstructured after the effective binding to calmodulin. Proteins 2003, 53, 855-862.
62. Uversky, V. N., Permyakov, S. E., Zagranichny, V. E., Rodionov, I. L. et al., Effect of zinc and temperature on the conformation of the gamma subunit of retinal phosphodiesterase: A natively unfolded protein. J. Proteome Res. 2002, 1, 149-159.
63. Timm, D. E., Vissavajjhala, P., Ross, A. H., Neet, K. E., Spectroscopic and chemical studies of the interaction between nerve growth factor (NGF) and the extracellular domain of the low affinity NGF receptor. Protein Sci. 1992, 1, 1023-1031.
64. Kim, T. D., Ryu, H. J., Cho, H. I., Yang, C. H., Kim, J., Thermal behavior of proteins: Heat-resistant proteins and their heat-induced secondary structural changes. Biochemistry 2000, 39, 14839-14846.
65. Urry, D. W., Entropic elastic processes in protein mechanisms. I. Elastic structure due to an inverse temperature transition and elasticity due to internal chain dynamics. J. Protein Chem. 1988, 7, 1-34.
66. Urry, D. W., Free energy transduction in polypeptides and proteins based on inverse temperature transitions. Prog. Biophys. Mol. Biol. 1992, 57, 23-57.
67. Urry, D. W., Physical chemistry of biological free energy transduction as demonstrated by elastic protein-based polymers. J. Phys. Chem.B 1997, 101, 11007-11028.
68. Meyer, D. E., Chilkoti, A., Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat. Biotechnol. 1999, 17, 1112-1115.
69. Hassouneh, W., MacEwan, S. R., Chilkoti, A., Fusions of elastin-like polypeptides to pharmaceutical proteins. Methods Enzymol. 2012, 502, 215-237.
70. Zhang, Y. J., Trabbic-Carlson, K., Albertorio, F., Chilkoti, A., Cremer, P. S., Aqueous two-phase system formation kinetics for elastin-like polypeptides of varying chain length. Biomacromolecules 2006, 7, 2192-2199.
71. Meyer, D. E., Chilkoti, A., Quantification of the effects of chain length and concentration on the thermal behavior of elastin-like polypeptides. Biomacromolecules 2004, 5, 846-851.
72. Chilkoti, A., Dreher, M. R., Meyer, D. E., Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Adv. Drug Deliv. Rev. 2002, 54, 1093-1111.
73. Urry, D. W., Luan, C. H., Parker, T. M., Gowda, D. C. et al., Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity. J. Am. Chem. Soc 1991, 113, 4346-4348.
74. McDaniel, J. R., Radford, D. C., Chilkoti, A., A unified model for de novo design of elastin-like polypeptides with tunable inverse transition temperatures. Biomacromolecules 2013, 14, 2866-2872.
75. Uversky, V. N., Gillespie, J. R., Millett, I. S., Khodyakova, A. V. et al., Natively unfolded human prothymosin alpha adopts partially folded collapsed conformation at acidic pH. Biochemistry 1999, 38, 15009-15016.
76. Konno, T., Tanaka, N., Kataoka, M., Takano, E., Maki, M., A circular dichroism study of preferential hydration and alcohol effects on a denatured protein, pig calpastatin domain I. Biochim. Biophys. Acta 1997, 1342, 73-82.
77. Lynn, A., Chandra, S., Malhotra, P., Chauhan, V. S., Heme binding and polymerization by Plasmodium falciparum histidine rich protein II: Influence of pH on activity and conformation. FEBS Lett. 1999, 459, 267-271.
78. Johansson, J., Gudmundsson, G. H., Rottenberg, M. E, Berndt, K. D., Agerberth, B., Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 1998, 273, 3718-3724.
79. Cortese, M. S., Baird, J. P., Uversky, V. N., Dunker, A. K., Uncovering the unfoldome: Enriching cell extracts for unstructured proteins by acid treatment. J. Proteome Res. 2005, 4, 1610-1618.
80. Csizmok, V., Szollosi, E., Friedrich, P., Tompa, P., A novel two-dimensional electrophoresis technique for the identification of intrinsically unstructured proteins. Mol. Cell Proteomics 2006, 5, 265-273.
81. Galea, C. A., Pagala, V. R., Obenauer, J. C., Park, C. G. et al., Proteomic studies of the intrinsically unstructured mammalian proteome. J. Proteome Res. 2006, 5, 2839-2848.
82. Oldfield, C. J., Cheng, Y., Cortese, M. S., Brown, C. J. et al., Comparing and combining predictors of mostly disordered proteins. Biochemistry 2005, 44, 1989-2000.
83. Uversky, V. N., A protein-chameleon: Conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J. Biomol. Struct. Dyn. 2003, 21, 211-234.
84. Kriwacki, R. W., Hengst, L., Tennant, L., Reed, S. I., Wright, P. E., Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: Conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. USA 1996, 93, 11504-11509.
85. Lacy, E. R., Filippov, I., Lewis, W. S., Otieno, S. et al., p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nat. Struct. Mol. Biol. 2004, 11, 358-364.
86. Bienkiewicz, E. A., Adkins, J. N., Lumb, K. J., Functional consequences of preorganized helical structure in the intrinsically disordered cell-cycle inhibitor p27(Kip1). Biochemistry 2002, 41, 752-759.
87. Hengst, L., Dulic, V., Slingerland, J. M., Lees, E., Reed, S. I., A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 1994, 91, 5291-5295.
88. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., Lansbury, P. T., NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 1996, 35, 13709-13715.
89. Uversky, V. N., Li, J., Fink, A. L., Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 2001, 276, 10737-10744.
90. Li, J., Uversky, V. N., Fink, A. L., Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry 2001, 40, 11604-11613.
91. Uversky, V. N., Permyakov, S. E., Zagranichny, V. E., Rodionov, I. L. et al., Effect of zinc and temperature on the conformation of the gamma subunit of retinal phosphodiesterase: A natively unfolded protein. J. Proteome Res. 2002, 1, 149-159.
92. Uversky, V. N., Li, J., Souillac, P., Millett, I. S. et al., Biophysical properties of the synucleins and their propensities to fibrillate: Inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J. Biol. Chem. 2002, 277, 11970-11978.
93. Hackel, M., Konno, T., Hinz, H., A new alternative method to quantify residual structure in 'unfolded' proteins. Biochim. Biophys. Acta 2000, 1479, 155-165.
94. Belmont, L. D., Mitchison, T. J., Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 1996, 84, 623-631.
95. Hernandez, M. A., Avila, J., Andreu, J. M., Physicochemical characterization of the heat-stable microtubule-associated protein MAP2. Eur. J. Biochem. 1986, 154, 41-48.
96. Kalthoff, C., A novel strategy for the purification of recombinantly expressed unstructured protein domains. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 786, 247-254.
97. Meyer, D. E., Trabbic-Carlson, K., Chilkoti, A., Effect of polypeptide length on the purification of thioredoxin. Biotechnol. Prog. 2001, 17, 720-728.
98. Hassouneh, W., Fischer, K., MacEwan, S. R., Branscheid, R. et al., Unexpected multivalent display of proteins by temperature triggered self-assembly of elastin-like polypeptide block copolymers. Biomacromolecules 2012, 13, 1598-1605.
99. Hassouneh, W., Christensen, T., Chilkoti, A., Elastin-like polypeptides as a purification tag for recombinant proteins. Curr. Protoc. Protein 2010, 61, 6.11.1-6.11.16.
100. Liu, W. J., Wu, Q., Xu, B., Zhang, X. Y. et al., Single-step purification of recombinant proteins using elastin-like peptide-mediated inverse transition cycling and self-processing module from Neisseria meningitides FrpC. Protein Expr. Purif. 2014, 98, 18-24.
101. Liu, W., Dreher, M. R., Furgeson, D. Y., Peixoto, K. V. et al., Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J. Control. Release 2006, 116, 170-178.
102. Paiva, L. R., Martins, M. L., A multiscale model to evaluate the efficacy of anticancer therapies based on chimeric polypeptide nanoparticles. Appl. Phys. Lett. 2011, 98, 053703.1-053703.3.
103. Janib, S. M., Liu, S., Park, R., Pastuszka, M. K. et al., Kinetic quantification of protein polymer nanoparticles using non-invasive imaging. Integr. Biol. (Camb.) 2013, 5, 183-194.
104. McDaniel, J. R., Bhattacharyya, J., Vargo, K. B., Hassouneh, W. et al., Self-assembly of thermally responsive nanoparticles of a genetically encoded peptide polymer by drug conjugation. Angew. Chem. 2013, 52, 1683-1687.
105. MacKay, J. A., Chen, M., McDaniel, J. R., Liu, W. et al., Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat. Mater. 2009, 8, 993-999.
106. McDaniel, J. R., MacEwan, S. R., Li, X., Radford, D. C. et al., Rational design of "heat seeking" drug loaded polypeptide nanoparticles that thermally target solid tumors. Nano Lett. 2014, 14, 2890-2895.
107. Bidwell, G. L., III, Raucher, D., Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy. Mol. Cancer Ther. 2005, 4, 1076-1085.
108. Massodi, I., Bidwell, G. L., III, Raucher, D., Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. J. Control. Release 2005, 108, 396-408.
109. Bidwell, G. L., III, Fokt, I., Priebe, W., Raucher, D., Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. Biochem. Pharmacol. 2007, 73, 620-631.
110. Bidwell, G. L., III, Davis, A. N., Raucher, D., Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides. J. Control. Release 2009, 135, 2-10.
111. Massodi, I., Thomas, E., Raucher, D., Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. Molecules 2009, 14, 1999-2015.
112. Bidwell, G. L., III, Raucher, D., Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. Adv. Drug Deliv. Rev. 2010, 62, 1486-1496.
113. Ryu, J. S., Raucher, D., Elastin-like polypeptides: The influence of its molecular weight on local hyperthermia-induced tumor accumulation., Eur. J. Pharm. Biopharm. 2014, doi: 10.1016/j.ejpb.2014.05.016.
114. Lyons, D. F., Le, V., Bidwell, G. L., III, Kramer, W. H. et al., Structural and hydrodynamic analysis of a novel drug delivery vector: ELP[V5G3A2-150]. Biophys. J. 2013, 104, 2009-2021.
115. Urry, D. W., Shaw, R. G., Prasad, K. U., Polypentapeptide of elastin: Temperature dependence of ellipticity and correlation with elastomeric force. Biochem. Biophys. Res. Commun. 1985, 130, 50-57.
116. Reiersen, H., Clarke, A. R., Rees, A. R., Short elastin-like peptides exhibit the same temperature-induced structural transitions as elastin polymers: Implications for protein engineering. J. Mol. Biol. 1998, 283, 255-264.
117. Gross, P. C., Possart, W., Zeppezauer, M., An alternative structure model for the polypentapeptide in elastin. Z. Naturforsch. C 2003, 58, 873-878.
118. Nicolini, C., Ravindra, R., Ludolph, B., Winter, R., Characterization of the temperature- and pressure-induced inverse and reentrant transition of the minimum elastin-like polypeptide GVG(VPGVG) by DSC, PPC, CD, and FT-IR spectroscopy. Biophys. J. 2004, 86, 1385-1392.
119. Lyons, D. F., Le, V., Kramer, W. H., Bidwell, G. L., III et al., Effect of basic cell-penetrating peptides on the structural, thermodynamic, and hydrodynamic properties of a novel drug delivery vector, ELP[V5G3A2-150]. Biochemistry 2014, 53, 1081-1091.
120. Massodi, I., Moktan, S., Rawat, A., Bidwell, G. L., III, Raucher, D., Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier. Int. J. Cancer 2010, 126, 533-544.
121. Mikecin, A. M., Walker, L. R., Kuna, M., Raucher, D., Thermally targeted p21 peptide enhances bortezomib cytotoxicity in androgen-independent prostate cancer cell lines. Anticancer Drugs 2014, 25, 189-199.
122. Massodi, I., Raucher, D., A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells. J. Drug Target. 2007, 15, 611-622.
123. Shamji, M. F., Chen, J., Friedman, A. H., Richardson, W. J. et al., Synthesis and characterization of a thermally-responsive tumor necrosis factor antagonist. J. Control. Release 2008, 129, 179-186.
124. de Marco, A., Protocol for preparing proteins with improved solubility by co-expressing with molecular chaperones in Escherichia coli. Nat. Protoc. 2007, 2, 2632-2639.
125. de Marco, A., Deuerling, E., Mogk, A., Tomoyasu, T., Bukau, B., Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli. BMC Biotechnol. 2007, 7, 32.
126. Gottesman, S., Zipser, D., xx, xx, xx, xx et al., Deg phenotype of Escherichia coli lon mutants. J. Bacteriol. 1978, 133, 844-851.
127. Itakura, K., Hirose, T., Crea, R., Riggs, A. D. et al., Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 1977, 198, 1056-1063.
128. Shen, S. H., Multiple joined genes prevent product degradation in Escherichia coli. Proc. Natl. Acad. Sci. USA 1984, 81, 4627-4631.
129. Abrahmsen, L., Moks, T., Nilsson, B., Uhlen, M., Secretion of heterologous gene products to the culture medium of Escherichia coli. Nucleic Acids Res. 1986, 14, 7487-7500.
130. Nilsson, B., Abrahmsen, L., Uhlen, M., Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors. EMBO J. 1985, 4, 1075-1080.
131. Zhan, Y., Song, X., Zhou, G. W., Structural analysis of regulatory protein domains using GST-fusion proteins. Gene 2001, 281, 1-9.
132. di Guan, C., Li, P., Riggs, P. D., Inouye, H., Vectors that facilitate the expression and purification of foreign peptides in Escherichia coli by fusion to maltose-binding protein. Gene 1988, 67, 21-30.
133. LaVallie, E. R., DiBlasio, E. A., Kovacic, S., Grant, K. L. et al., A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (NY) 1993, 11, 187-193.
134. Smith, D. B., Johnson, K. S., Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988, 67, 31-40.
135. Davis, G. D., Elisee, C., Newham, D. M., Harrison, R. G., New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol. Bioeng. 1999, 65, 382-388.
136. Vaillancourt, P., Simcox, T. G., Zheng, C. F., Recovery of polypeptides cleaved from purified calmodulin-binding peptide fusion proteins. Biotechniques 1997, 22, 451-453.
137. Zhang, Y. B., Howitt, J., McCorkle, S., Lawrence, P. et al., Protein aggregation during overexpression limited by peptide extensions with large net negative charge. Protein Expr. Purif. 2004, 36, 207-216.
138. Santner, A. A., Croy, C. H., Vasanwala, F. H., Uversky, V. N. et al., Sweeping away protein aggregation with entropic bristles: Intrinsically disordered protein fusions enhance soluble expression. Biochemistry 2012, 51, 7250-7262.
139. Napper, D. H. (Ed.), Stabilization by attached polymer: Steric stabilization., Academic Press, London 1983, pp. 18-30.
140. Milner, S. T., Polymer brushes. Science 1991, 251, 905-914.
141. Zanghellini, A., De novo computational enzyme design. Curr. Opin. Biotechnol. 2014, 29C, 132-138.
142. Dahiyat, B. I., Sarisky, C. A., Mayo, S. L., De novo protein design: Towards fully automated sequence selection. J. Mol. Biol. 1997, 273, 789-796.
143. Dahiyat, B. I., Mayo, S. L., De novo protein design: Fully automated sequence selection. Science 1997, 278, 82-87.